Cargando…

Advances in targeted therapy for esophageal cancer

Esophageal cancer (EC) is one of the most lethal cancers in the world, and its morbidity and mortality rates rank among the top ten in China. Currently, surgical resection, radiotherapy and chemotherapy are the primary clinical treatments for esophageal cancer. However, outcomes are still unsatisfac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yan-Ming, Hong, Pan, Xu, Wen Wen, He, Qing-Yu, Li, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542465/ https://www.ncbi.nlm.nih.gov/pubmed/33028804 http://dx.doi.org/10.1038/s41392-020-00323-3

Ejemplares similares

Advances in targeted therapy and immunotherapy for esophageal cancer
por: Yang, Haiou, et al.
Publicado: (2023)

Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015)

Esophageal cancer: Recent advances in screening, targeted therapy, and management
por: Gaur, Puja, et al.
Publicado: (2014)

Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance
por: Hu, Hui-Fang, et al.
Publicado: (2020)

Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis
por: Hong, Pan, et al.
Publicado: (2020)

Advances and challenges in the treatment of esophageal cancer
por: He, Shiming, et al.
Publicado: (2021)

Targeting PI3K/Akt signal transduction for cancer therapy
por: He, Yan, et al.
Publicado: (2021)

Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis
por: Xu, Wen Wen, et al.
Publicado: (2021)

Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
por: Ooki, Akira, et al.
Publicado: (2023)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
por: Barsouk, Adam, et al.
Publicado: (2019)

Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2‐ERK Signaling to Suppress Esophageal Cancer Metastasis
por: Xu, Wen Wen, et al.
Publicado: (2020)

Recent advances in targeted therapy for pancreatic adenocarcinoma
por: Fang, Yu-Ting, et al.
Publicado: (2023)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
por: Huang, Runkai, et al.
Publicado: (2022)

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
por: Li, Bin, et al.
Publicado: (2017)

Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
por: Xu, Wen Wen, et al.
Publicado: (2014)

Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance
por: Li, Bin, et al.
Publicado: (2019)

Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Advancements in photodynamic therapy of esophageal cancer
por: Bartusik-Aebisher, Dorota, et al.
Publicado: (2022)

Advances in targeted therapy for malignant lymphoma
por: Wang, Li, et al.
Publicado: (2020)

Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer
por: Hou, Xiaobin, et al.
Publicado: (2017)

The progress of targeted therapy in advanced gastric cancer
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021)

An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy
por: Xiong, Teng, et al.
Publicado: (2017)

RAS‐targeted cancer therapy: Advances in drugging specific mutations
por: Liu, Cen, et al.
Publicado: (2023)

Editorial: Frontiers' research topic “advances in esophageal cancer surgery with neoadjuvant therapies”
por: Shang, Qi-Xin, et al.
Publicado: (2023)

Advances in Radiotherapy Management of Esophageal Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy
por: Xu, Jiangsheng, et al.
Publicado: (2022)

Advancement and prospects of tumor gene therapy
por: Zhang, Chao, et al.
Publicado: (2011)

Preoperative therapy in locally advanced esophageal cancer
por: Garg, Pankaj Kumar, et al.
Publicado: (2016)

Management of Locally Advanced Esophageal Cancer
por: Thakur, Binay, et al.
Publicado: (2021)

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer
por: Hou, Sicong, et al.
Publicado: (2021)

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
por: Zhong, Lei, et al.
Publicado: (2021)

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
por: Dragovich, Tomislav, et al.
Publicado: (2009)

Clinical Evaluation of Transarterial Infusion Chemotherapy for Advanced Esophageal Cancer
por: Yin, Mei-Pan, et al.
Publicado: (2021)

Pathological characteristics of esophageal cancer
por: SHI, HONG-YUN, et al.
Publicado: (2014)

Photodynamic Therapy for Esophageal Cancer
por: Inoue, Takahiro, et al.
Publicado: (2021)

Advances in the targeted therapy of liposarcoma
por: Guan, Zhonghai, et al.
Publicado: (2015)

Advances in dosimetry and biological predictors of radiation-induced esophagitis
por: Yu, Yang, et al.
Publicado: (2016)

Selection of minimally invasive surgical approaches for treating esophageal cancer
por: Lee, Yu‐Kwang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ua827b4ds56e1l9otdp25mbc53